home / stock / ctabf / ctabf quote
Last: | $0.0073 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0073 |
Close: | $0.0073 |
High: | $0.0073 |
Low: | $0.0073 |
Volume: | 2,000 |
Last Trade Date Time: | 03/13/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0073 | $0.0073 | $0.0073 | $0.0073 | $0.0073 | 2,000 | 03-13-2024 |
$0.0016 | $0.0016 | $0.0016 | $0.0016 | $0.0016 | 5,000 | 03-11-2024 |
$0.0073 | $0.0073 | $0.0073 | $0.0073 | $0.0073 | 1,500 | 03-07-2024 |
$0.0018 | $0.0018 | $0.0018 | $0.0018 | $0.0018 | 135 | 02-27-2024 |
$0.0032 | $0 | $0.0032 | $0 | $0 | 1 | 02-26-2024 |
$0.0032 | $0.0032 | $0.0032 | $0.0032 | $0.0032 | 42,000 | 02-12-2024 |
$0.0032 | $0.0032 | $0.0032 | $0.0032 | $0.0032 | 5,000 | 02-07-2024 |
$0.0091 | $0.0091 | $0.0091 | $0.0091 | $0.0091 | 450 | 01-25-2024 |
$0.0091 | $0.0091 | $0.0091 | $0.0091 | $0.0091 | 100 | 01-11-2024 |
$0.0091 | $0.0091 | $0.0091 | $0.0091 | $0.0091 | 2,000 | 01-01-2024 |
$0.0091 | $0.0091 | $0.0091 | $0.0091 | $0.0091 | 2,000 | 12-29-2023 |
$0.009 | $0.0028 | $0.009 | $0.009 | $0.0028 | 11,800 | 12-19-2023 |
$0.00205 | $0.00205 | $0.00205 | $0.00205 | $0.00205 | 170 | 12-18-2023 |
$0.00215 | $0 | $0.00215 | $0 | $0 | 1 | 12-13-2023 |
$0.00215 | $0 | $0.00215 | $0 | $0 | 1 | 12-08-2023 |
$0.00215 | $0.00215 | $0.00215 | $0.00215 | $0.00215 | 1,000 | 11-20-2023 |
$0.0021 | $0.0021 | $0.0021 | $0.0021 | $0.0021 | 1,000 | 11-01-2023 |
$0.00235 | $0.0036 | $0.00235 | $0.0036 | $0.00235 | 51,064 | 10-03-2023 |
$0.0074 | $0.007 | $0.0074 | $0.0074 | $0.007 | 10,100 | 09-29-2023 |
$0.007 | $0.007 | $0.007 | $0.007 | $0.007 | 24,444 | 09-28-2023 |
News, Short Squeeze, Breakout and More Instantly...
Canntab Therapeutics Ltd Company Name:
CTABF Stock Symbol:
OTCMKTS Market:
Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the " Corporation ") announces that the Ontario Securities Commission (the " OSC ") has rejected the Corporation's application for a management cease trade order (the ...
TORONTO, ON / ACCESSWIRE / November 22, 2022 / Canntab Therapeutics Limited (CSE:PILL)(OTCQB:CTABF)(FRA:TBF1) (the " Company " or " Canntab ") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is providing an update on several matters impac...
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET Canada NewsWire TORONTO , Aug. 22, 2022 /CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the " Company " or " Canntab ") a leading innovator in cannabi...